JP2023539883A5 - - Google Patents
Info
- Publication number
- JP2023539883A5 JP2023539883A5 JP2023514027A JP2023514027A JP2023539883A5 JP 2023539883 A5 JP2023539883 A5 JP 2023539883A5 JP 2023514027 A JP2023514027 A JP 2023514027A JP 2023514027 A JP2023514027 A JP 2023514027A JP 2023539883 A5 JP2023539883 A5 JP 2023539883A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- region
- bispecific antibody
- listed
- molecule according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025154628A JP2026016364A (ja) | 2020-09-02 | 2025-09-18 | 抗ａｂｃｃ１抗体及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063073826P | 2020-09-02 | 2020-09-02 | |
| US63/073,826 | 2020-09-02 | ||
| PCT/US2021/048701 WO2022051390A1 (en) | 2020-09-02 | 2021-09-01 | Anti-abcc1 antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154628A Division JP2026016364A (ja) | 2020-09-02 | 2025-09-18 | 抗ａｂｃｃ１抗体及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023539883A JP2023539883A (ja) | 2023-09-20 |
| JP2023539883A5 true JP2023539883A5 (enExample) | 2024-09-06 |
| JP7747741B2 JP7747741B2 (ja) | 2025-10-01 |
Family
ID=78087510
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514027A Active JP7747741B2 (ja) | 2020-09-02 | 2021-09-01 | 抗ａｂｃｃ１抗体及びその使用 |
| JP2025154628A Pending JP2026016364A (ja) | 2020-09-02 | 2025-09-18 | 抗ａｂｃｃ１抗体及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154628A Pending JP2026016364A (ja) | 2020-09-02 | 2025-09-18 | 抗ａｂｃｃ１抗体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230272117A1 (enExample) |
| EP (1) | EP4208483A1 (enExample) |
| JP (2) | JP7747741B2 (enExample) |
| KR (1) | KR20230061429A (enExample) |
| CN (1) | CN116490522A (enExample) |
| AU (1) | AU2021338286A1 (enExample) |
| CA (1) | CA3193588A1 (enExample) |
| WO (1) | WO2022051390A1 (enExample) |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| TW197439B (enExample) | 1991-04-04 | 1993-01-01 | Ueno Pharmaceutics Applic Res Co Ltd | |
| US5283253A (en) | 1991-09-23 | 1994-02-01 | Florida State University | Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them |
| WO1993010076A1 (en) | 1991-11-22 | 1993-05-27 | The University Of Mississippi | Synthesis and optical resolution of the taxol side chain and related compounds |
| ATE207080T1 (de) | 1991-11-25 | 2001-11-15 | Enzon Inc | Multivalente antigen-bindende proteine |
| US5200534A (en) | 1992-03-13 | 1993-04-06 | University Of Florida | Process for the preparation of taxol and 10-deacetyltaxol |
| JPH08500973A (ja) | 1992-05-21 | 1996-02-06 | ザ ペン ステイト リサーチ ファウンデーション | タキソール、関連タキサン及び他の新規な抗癌／抗ウイルス性化合物原料としてのイチイ培養組織 |
| US5274137A (en) | 1992-06-23 | 1993-12-28 | Nicolaou K C | Intermediates for preparation of taxols |
| US5294637A (en) | 1992-07-01 | 1994-03-15 | Bristol-Myers Squibb Company | Fluoro taxols |
| US5202448A (en) | 1992-08-14 | 1993-04-13 | Napro Biotherapeutics, Inc. | Processes of converting taxanes into baccatin III |
| CA2100808A1 (en) | 1992-10-01 | 1994-04-02 | Vittorio Farina | Deoxy paclitaxels |
| FR2696463B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
| FR2696458B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Procédé de préparation de dérivés du taxane. |
| FR2696464B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III. |
| FR2696462B1 (fr) | 1992-10-05 | 1994-11-25 | Rhone Poulenc Rorer Sa | Procédé d'obtention de la désacétyl-10 baccatine III. |
| FR2696461B1 (fr) | 1992-10-05 | 1994-11-10 | Rhone Poulenc Rorer Sa | Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent. |
| US5279949A (en) | 1992-12-07 | 1994-01-18 | Board Of Trustees Operating Michigan State University | Process for the isolation and purification of taxol and taxanes from Taxus spp |
| US5824701A (en) | 1993-10-20 | 1998-10-20 | Enzon, Inc. | Taxane-based prodrugs |
| US5415869A (en) | 1993-11-12 | 1995-05-16 | The Research Foundation Of State University Of New York | Taxol formulation |
| AU3740997A (en) | 1996-08-26 | 1998-03-19 | Bristol-Myers Squibb Company | Sulfenamide taxane derivatives |
| WO1998013059A1 (en) | 1996-09-27 | 1998-04-02 | Bristol-Myers Squibb Company | Hydrolyzable prodrugs for delivery of anticancer drugs to metastatic cells |
| AU4966597A (en) | 1996-11-19 | 1998-06-10 | Daiichi Pharmaceutical Co., Ltd. | Taxol derivatives |
| US5977386A (en) | 1996-12-24 | 1999-11-02 | Bristol-Myers Squibb Company | 6-thio-substituted paclitaxels |
| JP2002505682A (ja) | 1997-06-20 | 2002-02-19 | ベーカー ノートン ファーマシューティカルズ インコーポレイテッド | パクリタクセルの可溶性プロドラッグ |
| US7288665B1 (en) | 1997-08-18 | 2007-10-30 | Florida State University | Process for selective derivatization of taxanes |
| JPH1192468A (ja) | 1997-09-17 | 1999-04-06 | Yakult Honsha Co Ltd | 新規なタキサン誘導体 |
| WO1999018113A1 (fr) | 1997-10-08 | 1999-04-15 | Bio Research Corporation Of Yokohama | Derives taxoides et leur procede de production |
| JP2004051553A (ja) * | 2002-07-19 | 2004-02-19 | Chugai Pharmaceut Co Ltd | 抗ｍｒｐ１抗体を含有する抗癌剤の抗癌作用増強剤 |
-
2021
- 2021-09-01 CA CA3193588A patent/CA3193588A1/en active Pending
- 2021-09-01 JP JP2023514027A patent/JP7747741B2/ja active Active
- 2021-09-01 CN CN202180073919.1A patent/CN116490522A/zh active Pending
- 2021-09-01 AU AU2021338286A patent/AU2021338286A1/en active Pending
- 2021-09-01 KR KR1020237010630A patent/KR20230061429A/ko active Pending
- 2021-09-01 EP EP21790651.0A patent/EP4208483A1/en active Pending
- 2021-09-01 WO PCT/US2021/048701 patent/WO2022051390A1/en not_active Ceased
- 2021-09-01 US US18/043,675 patent/US20230272117A1/en active Pending
-
2025
- 2025-09-18 JP JP2025154628A patent/JP2026016364A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022541435A5 (enExample) | ||
| JP2024522360A5 (enExample) | ||
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| JP2021533726A5 (enExample) | ||
| JP2022527151A5 (enExample) | ||
| JP2019527553A5 (enExample) | ||
| EA038880B1 (ru) | Гуманизированные моноклональные антитела, моноклональные антитела мыши или химерные моноклональные антитела против cd47 | |
| JP2023540526A5 (enExample) | ||
| JP2020530272A5 (enExample) | ||
| JP2026041845A5 (enExample) | ||
| JP2023528416A5 (enExample) | ||
| JP2020534830A5 (enExample) | ||
| JP2018520668A5 (enExample) | ||
| JP2018522888A5 (enExample) | ||
| JP2023509390A5 (enExample) | ||
| JP2024001073A5 (enExample) | ||
| JP2023527937A5 (enExample) | ||
| JP2017521054A5 (enExample) | ||
| JP2024506315A5 (enExample) | ||
| JP2025514636A5 (enExample) | ||
| JP2022539589A5 (enExample) | ||
| JP2023536631A5 (enExample) | ||
| JP2025508317A5 (enExample) | ||
| JP2025505650A5 (enExample) | ||
| JP2025506143A5 (enExample) |